SHH and neoplasm: Micromolar concentration of phenformin, which may be regarded as clinically relevant, exerted an inhibitory effect on tumor growth and Shh signaling that was independent of complex I inhibition and AMPK activation, and linked to the inhibition of mGPDH activity and the increase of intracellular NADH content.